In 2011, the Institute of Medicine (IOM), a non-profit group affiliated with the US National Academy of Sciences, reviewed a study measuring bone quality and levels of vitamin-D in a random sample from bodies of 675 people who died in good health. 8.5% of the 82 bodies with low vitamin-D levels (below 50 nmol/L) had weak bones. Comparatively, 1% of the 593 bodies with regular vitamin-D levels had weak bones. Is a normal model a good fit for the sampling distribution?